A detailed history of Asset Advisors Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Asset Advisors Investment Management, LLC holds 97,818 shares of ABBV stock, worth $16.7 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
97,818
Previous 92,401 5.86%
Holding current value
$16.7 Million
Previous $16.8 Million 0.29%
% of portfolio
1.83%
Previous 1.89%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $838,497 - $979,176
5,417 Added 5.86%
97,818 $16.8 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $476,583 - $543,022
2,982 Added 3.33%
92,401 $16.8 Million
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $109,942 - $123,821
799 Added 0.9%
89,419 $13.9 Million
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $142,540 - $165,011
-1,067 Reduced 1.19%
88,620 $13.2 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $351,151 - $436,985
-2,650 Reduced 2.87%
89,687 $12.1 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $13,304 - $15,321
92 Added 0.1%
92,337 $14.7 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $82,986 - $99,522
-600 Reduced 0.65%
92,245 $14.9 Million
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $30,197 - $34,634
-225 Reduced 0.24%
92,845 $12.5 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $488,551 - $621,108
-3,550 Reduced 3.67%
93,070 $14.3 Million
Q1 2022

Apr 22, 2022

BUY
$131.98 - $163.75 $557,615 - $691,843
4,225 Added 4.57%
96,620 $15.7 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $397,491 - $502,941
-3,700 Reduced 3.85%
92,395 $12.5 Million
Q3 2021

Oct 29, 2021

SELL
$106.4 - $120.78 $1.43 Million - $1.63 Million
-13,485 Reduced 12.31%
96,095 $10.4 Million
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $210,420 - $234,420
2,000 Added 1.86%
109,580 $12.3 Million
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $5,115 - $5,631
-50 Reduced 0.05%
107,580 $11.6 Million
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $395,849 - $534,439
4,918 Added 4.79%
107,630 $11.5 Million
Q3 2020

Oct 20, 2020

SELL
$85.91 - $100.83 $232,128 - $272,442
-2,702 Reduced 2.56%
102,712 $9 Million
Q2 2020

Jul 21, 2020

SELL
$73.37 - $98.18 $100,223 - $134,113
-1,366 Reduced 1.28%
105,414 $10.4 Million
Q1 2020

Apr 23, 2020

SELL
$64.5 - $97.79 $143,835 - $218,071
-2,230 Reduced 2.05%
106,780 $8.14 Million
Q4 2019

Jan 22, 2020

BUY
$72.13 - $90.25 $648,448 - $811,347
8,990 Added 8.99%
109,010 $9.62 Million
Q3 2019

Oct 23, 2019

BUY
$62.98 - $75.72 $130,683 - $157,119
2,075 Added 2.12%
100,020 $7.57 Million
Q2 2019

Jul 25, 2019

BUY
$65.7 - $83.98 $56,173 - $71,802
855 Added 0.88%
97,945 $7.12 Million
Q1 2019

Apr 16, 2019

BUY
$77.14 - $90.79 $26,999 - $31,776
350 Added 0.36%
97,090 $7.82 Million
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $111,325 - $137,294
1,430 Added 1.5%
96,740 $8.92 Million
Q3 2018

Oct 26, 2018

BUY
$88.91 - $98.84 $8.47 Million - $9.42 Million
95,310 New
95,310 $9.01 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Asset Advisors Investment Management, LLC Portfolio

Follow Asset Advisors Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.